Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/5/2025 | $39.00 | Outperform → Mkt Perform | Keefe Bruyette |
| 12/6/2023 | $29.00 | Neutral | UBS |
| 11/13/2023 | $30.00 | Neutral → Buy | BofA Securities |
| 5/9/2023 | $25.00 → $27.00 | Underperform → Neutral | BofA Securities |
| 2/8/2023 | $25.00 → $26.50 | Mkt Perform → Outperform | Keefe Bruyette |
| 1/9/2023 | $24.50 | Neutral → Underperform | Credit Suisse |
| 9/6/2022 | $27.00 | Overweight → Neutral | JP Morgan |
| 8/18/2022 | $25.00 | Neutral → Underperform | BofA Securities |
Genworth Financial, Inc. (NYSE:GNW) announced the election of all ten director nominees at its 2025 annual meeting of stockholders today. The board members re-elected were G. Kent Conrad, Karen E. Dyson, Jill R. Goodman, Melina E. Higgins, Thomas J. McInerney, Howard D. Mills, III, Robert P. Restrepo Jr., Elaine A. Sarsynski, Ramsey D. Smith, and Steven C. Van Wyk. At the annual meeting, stockholders also approved the advisory vote on named executive officer compensation and the 2025 Omnibus Incentive Plan. In addition, stockholders ratified the selection of KPMG LLP as Genworth's independent registered public accounting firm for 2025. In addition, stockholders approved an amendment to th
GAAP Net Income of $166 million, or $1.08 per diluted share Adjusted Operating Income of $169 million, or $1.10 per diluted share Return on Equity of 13.1% and Adjusted Operating Return on Equity of 13.4% Primary Insurance in-force of $268 billion, a 2% increase from first quarter 2024 PMIERs Sufficiency of 165% or approximately $2.0 billion Book Value Per Share of $33.96 and Book Value Per Share excluding AOCI of $34.97 RALEIGH, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) today announced financial results for the first quarter of 2025. "We had a strong start to 2025 and continue to make progress against our priorities," stated Rohit Gupta, President a
Strategic Highlights Executed $45M in share repurchases at an average price of $6.91 per share; $590M program-to-date through March 31, 2025 at an average price of $5.73 per share Continued progress on the LTC1 multi-year rate action plan with $24M of gross incremental premium approvals; approximately $31.3B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Strong progress made towards the expansion of the CareScout Quality Network, growing coverage to 90% of the aged 65-plus census population in the United States and delivered 576 matches in the first quarter Financial Highlights Net income2 of $54M, or $0.13 per diluted share, and adjusted operati
144 - Enact Holdings, Inc. (0001823529) (Subject)
8-K - Enact Holdings, Inc. (0001823529) (Filer)
10-Q - Enact Holdings, Inc. (0001823529) (Filer)
4 - Enact Holdings, Inc. (0001823529) (Issuer)
4 - Enact Holdings, Inc. (0001823529) (Issuer)
4 - Enact Holdings, Inc. (0001823529) (Issuer)